drugset / Trial / NCT02168439
Intranasal Dexmedetomidine vs Intranasal Midazolam as Anxiolysis Prior to Pediatric Laceration Repair
Phase 4
Completed
40 enrolled
University of Pittsburgh
National Center for Advancing Translational Sciences (NCATS) · collabUniversity of Pittsburgh Clinical and Translational Science Institute (CTSI) · collab
RandomizedParallel-groupQuadruple-blindSupportive care
Summary
The objective of this research study is to show superiority of intranasal dexmedetomidine to intranasal midazolam as anxiolysis prior to pediatric laceration repairs.
Timeline
- Start
- 2014-06
- Primary completion
- 2015-04
- Completion
- 2016-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Dexmedetomidine | Other / unclassified | 2 ug/kg | Intranasal |
| Subject | Midazolam | Small molecule | 0.4 mg/kg | Intranasal |